N. Schor

2.2k total citations
65 papers, 1.7k citations indexed

About

N. Schor is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Nephrology. According to data from OpenAlex, N. Schor has authored 65 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 18 papers in Molecular Biology and 17 papers in Nephrology. Recurrent topics in N. Schor's work include Kidney Stones and Urolithiasis Treatments (14 papers), Renin-Angiotensin System Studies (6 papers) and Nitric Oxide and Endothelin Effects (5 papers). N. Schor is often cited by papers focused on Kidney Stones and Urolithiasis Treatments (14 papers), Renin-Angiotensin System Studies (6 papers) and Nitric Oxide and Endothelin Effects (5 papers). N. Schor collaborates with scholars based in Brazil, United States and Italy. N. Schor's co-authors include Mírian Aparecida Boim, Fernanda Teixeira Borges, Luciana Aparecida Reis, Dulce Elena Casarini, Iekuni Ichikawa, M. A. Boim, Adriane Martins de Freitas, Márcio Eduardo de Barros, Priscila Cardoso Cristovam and B. M. Brenner and has published in prestigious journals such as Journal of Clinical Investigation, Neurology and Cancer.

In The Last Decade

N. Schor

63 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Schor Brazil 21 596 467 431 344 268 65 1.7k
Fuyuhiko Nishijima Japan 32 780 1.3× 192 0.4× 1.2k 2.7× 289 0.8× 266 1.0× 37 2.4k
Tatsuo Yamamoto Japan 24 551 0.9× 268 0.6× 677 1.6× 563 1.6× 362 1.4× 82 2.4k
Jesus H. Dominguez United States 26 739 1.2× 203 0.4× 611 1.4× 197 0.6× 367 1.4× 66 2.0k
John H. Dirks Canada 18 363 0.6× 356 0.8× 560 1.3× 101 0.3× 93 0.3× 47 1.3k
Terezila Machado Coimbra Brazil 28 783 1.3× 267 0.6× 826 1.9× 200 0.6× 225 0.8× 105 2.9k
Kyung Pyo Kang South Korea 28 804 1.3× 293 0.6× 472 1.1× 250 0.7× 142 0.5× 100 2.5k
Norishi Ueda Japan 20 545 0.9× 189 0.4× 518 1.2× 106 0.3× 59 0.2× 37 1.8k
Cindy J. Fuller United States 24 326 0.5× 777 1.7× 177 0.4× 91 0.3× 108 0.4× 40 2.0k
Maria Heloísa Massola Shimizu Brazil 26 425 0.7× 248 0.5× 446 1.0× 97 0.3× 147 0.5× 61 1.7k
Brian B. Ratliff United States 23 794 1.3× 211 0.5× 465 1.1× 146 0.4× 96 0.4× 43 2.0k

Countries citing papers authored by N. Schor

Since Specialization
Citations

This map shows the geographic impact of N. Schor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Schor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Schor more than expected).

Fields of papers citing papers by N. Schor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Schor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Schor. The network helps show where N. Schor may publish in the future.

Co-authorship network of co-authors of N. Schor

This figure shows the co-authorship network connecting the top 25 collaborators of N. Schor. A scholar is included among the top collaborators of N. Schor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Schor. N. Schor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Richards, William A., Yvan Beaussant, Rezvan Ameli, et al.. (2023). Psilocybin‐assisted group therapy in patients with cancer diagnosed with a major depressive disorder. Cancer. 130(7). 1137–1146. 33 indexed citations
2.
Weiss, Nicolas, Sylvain Choquet, Cristina Birzu, et al.. (2023). JS03.6.A NEUROTOXICITY IN PATIENTS WITH CNS LYMPHOMAS TREATED WITH CAR T CELL THERAPY. A LOC NETWORK STUDY. Neuro-Oncology. 25(Supplement_2). ii7–ii8. 1 indexed citations
3.
Dalboni, Maria Aparecida, et al.. (2010). Pro-inflammatory and oxidative effects of noncrystalline uric acid in human mesangial cells: contribution to hyperuricemic glomerular damage. Urological Research. 39(1). 21–27. 27 indexed citations
4.
Cenedeze, Marcos Antônio, et al.. (2009). Collagen XVIII/endostatin expression in experimental endotoxemic acute renal failure. Brazilian Journal of Medical and Biological Research. 42(12). 1150–1155. 6 indexed citations
5.
Borges, Fernanda Teixeira, et al.. (2008). The Effects of Lipopolysaccharide-Induced Reactive Oxygen Species Were Blunted by Calcium Oxalate in Renal Tubular Epithelial Cells. Nephron Experimental Nephrology. 108(2). e35–e44. 2 indexed citations
6.
Maciel, Thiago Trovati, et al.. (2006). Escherichia coli lipopolysaccharide inhibits renin activity in human mesangial cells. Kidney International. 69(6). 974–980. 22 indexed citations
7.
Campos, Alexandre Holthausen, et al.. (2004). Phyllanthus niruri normalizes elevated urinary calcium levels in calcium stone forming (CSF) patients. Urological Research. 32(5). 362–366. 63 indexed citations
8.
Casarini, Dulce Elena, et al.. (2004). High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells. American Journal of Physiology-Renal Physiology. 286(6). F1039–F1045. 178 indexed citations
9.
Schor, N., et al.. (2003). Effects of Gentamicin on Mouse Immortalized Mesangial Cells (MIMC). Renal Failure. 25(1). 1–4. 1 indexed citations
10.
Barros, Márcio Eduardo de, N. Schor, & Mírian Aparecida Boim. (2003). Effects of an aqueous extract from Phyllantus niruri on calcium oxalate crystallization in vitro. Urological Research. 30(6). 374–379. 90 indexed citations
11.
Freitas, Adriane Martins de, N. Schor, & Mírian Aparecida Boim. (2002). The effect of Phyllanthus niruri on urinary inhibitors of calcium oxalate crystallization and other factors associated with renal stone formation. British Journal of Urology. 89(9). 829–834. 101 indexed citations
12.
Schor, N., et al.. (2001). GASTROCYSTOPLASTY AND CHRONIC RENAL FAILURE: AN ACID-BASE METABOLISM STUDY. The Journal of Urology. 251–254. 1 indexed citations
13.
Boim, Mírian Aparecida, et al.. (2001). Evaluation of lithogenic elements in urine of healthy newborns. Pediatric Nephrology. 16(12). 1080–1083. 8 indexed citations
14.
Schor, N., et al.. (1999). Revisão: transportadores de água. Revista da Associação Médica Brasileira. 45(1). 71–78. 2 indexed citations
15.
Santos, Oscar Fernando Pavão dos, et al.. (1996). Fructose-1,6-Diphosphate: Potential Protection in Cyclosporine-lnduced Renal Impairment. ˜The œNephron journals/Nephron journals. 72(1). 67–71. 4 indexed citations
16.
Boim, M. A., et al.. (1992). Effect of Eicosapentaenoic Acid on the Progression of Chronic Renal Failure in Rats. ˜The œNephron journals/Nephron journals. 62(4). 449–453. 5 indexed citations
17.
Michelacci, Yára M., et al.. (1992). Possible role for chondroitin sulfate in urolithiasis: In vivo studies in an experimental model. Clinica Chimica Acta. 208(1-2). 1–8. 27 indexed citations
18.
Ajzen, H, et al.. (1991). Metabolic disturbance as a cause of recurrent hematuria in children. Pediatric Nephrology. 5(6). 707–707. 10 indexed citations
19.
Lugon, Jocemir Ronaldo, et al.. (1989). Renal function and glomerular hemodynamics in male endotoxemic rats. Kidney International. 36(4). 570–575. 70 indexed citations
20.
Schor, N., et al.. (1989). Effect of cisplatin on glomerular hemodynamics.. PubMed. 22(10). 1295–301. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026